Saturday June 23, 2018
Home Uncategorized Indian-origin...

Indian-origin Pharmacist Niren Patel Jailed for Illegally Selling Prescription Drugs

0
//
158
drugs, medicines
An Indian-origin pharmacist has been jailed by a court here for stealing prescription drugs worth 5,000 pounds. Pixabay
Republish
Reprint

London, June 17, 2017: An Indian-origin pharmacist has been jailed by a court here for stealing prescription drugs worth 5,000 pounds ($6,405) and then selling them on the street.

Niren Patel, 38, of Ilford, Essex, appeared at Snaresbrook Crown Court this week and pleaded guilty to two counts of fraud by abuse of a position of trust, possession with intent to supply a class B drug and five counts of possession to supply a class C drug.

The court was told that Patel, who worked at Day Lewis pharmacy in Hornchurch and Hedgemans Pharmacy in Dagenham, created fraudulent orders for prescription drugs worth 5,000 pounds, the Pharmaceutical Journal reported on Friday.

The drugs he sold included class C drugs such as Xanax, Diazepam, and the hypnotic Zolpidem.

He also stole the class B drug Dexamfetamine, used for weight loss and to improve academic performance, and Genotropin, a growth hormone used by bodybuilders.

During questioning by police, Patel admitted he sold the drugs on the street.

“Patel abused his position as a pharmacist… The drugs he sold are highly addictive and dangerous when given to someone without a prescription,” Detective Constable Beverley McInerney of the Met’s Organised Crime Command said. (IANS)

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Drugs That Suppress Immune System May Protect Against Parkinson’s

Immunosuppresive drugs likely to keep Parkinson's at bay

0
Drugs That Suppress Immune System May Protect Against Parkinson’s
Drugs That Suppress Immune System May Protect Against Parkinson’s. Pixabay

People who are on drugs to suppress their immune system are less likely to develop Parkinson’s disease — a neurological disorder characterised by tremors, slow movements, stiffness and difficulty walking, a new study claimed.

The results, published in the journal Annals of Clinical and Translational Neurology, showed that people with several types of autoimmune diseases, including ulcerative colitis were less likely to be diagnosed with Parkinson’s than the general population.

The investigators noted that many autoimmune diseases have one common thing, that is, they are treated with drugs that dampen immune activity.

“We’ve found that taking certain classes of immunosuppressant drugs reduces the risk of developing Parkinson’s. One group of drugs in particular looks really promising and warrants further investigation to determine whether it can slow disease progression,” said Brad Racette from Washington University-St. Louis in the US.

Representational image.
Representational image. Pixabay

The study showed that people taking corticosteroids — used for treating inflammatory diseases — such as prednisone were 20 per cent less likely to be diagnosed with Parkinson’s, while those on inosine monophosphate dehydrogenase (IMDH)– an enzyme — inhibitors were about one-third less likely.

While, immunosuppresive drugs may keep Parkinson’s at bay, it may ,however, increase the chances of developing infectious diseases and cancer.

The benefits of these drugs outweigh the costs for people with serious autoimmune diseases like rheumatoid arthritis but doctors would probably hesitate to prescribe risky drugs to healthy people to stave off Parkinson’s, especially since there is no reliable way to predict who is on track to develop the disease, the team explained.

Also Read: Cancer Patients Turn Incredible Photographers

“What we really need is a drug for people who are newly diagnosed, to prevent the disease from worsening. It’s a reasonable assumption that if a drug reduces the risk of getting Parkinson’s, it also will slow disease progression, and we’re exploring that now,” Racette said.

For the study, the team analysed prescription drug data on 48,295 people diagnosed with Parkinson’s and 52,324 people never diagnosed with Parkinson’s and developed an algorithm to predict which people would be diagnosed with the disease. (IANS)